ARCHIVES

An “insurgency” targets randomized trials, demands access to investigational drugs.

This article is from The Cancer Letter archive.

Vol. 31 No. 31 | August 5, 2005

Download PDF Visit The Full Archive

Related Articles

Erbitux Improves Survival In Advanced Colorectal Cancer

November 30, 2007

RFA For Patterns Of Care Study in Elderly Issues

January 14, 1983

HEW To Pay All Care Cost At 26 Hospices

January 11, 1980

Sen. Mack Seeks Research Funding For Shark Cartilage

July 29, 1994

ACS President Calls On Physicians To Take Advantage Of “Untapped Opportunities” In Cancer Prevention

March 27, 1987

Lame Duck NCI Director: Cancer Centers Should Run Cancer Clinical Trials System

June 25, 2010